HARTFORD, Conn. (Oct 3, 2016) – A law that sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients went into effect on Saturday. The Joint Insurance and Real Estate Committee introduced what would become Senate Bill 371 (SB371) in March,…
HARTFORD, Conn. (June 22, 2016) – Connecticut Gov. Daniel Malloy’ has signed a bill into law that sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. The Joint Insurance and Real Estate Committee introduced what would become Senate Bill 371…
HARTFORD, Conn. (May, 10, 2016) – The Connecticut legislature has passed a bill that sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. The Joint Insurance and Real Estate Committee introduced what would become Senate Bill 371 (SB371) in March,…